INCYTE CORPORATION Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax
INCYTE CORPORATION (INCY) had Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax of $39.92 million as of 2024-12-31, per its 10-K filed 2025-02-10.
Financial Statements › Notes › Compensation Related Costs › Defined Benefit Plan
us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax · last filed 2025-02-10
- 2024-12-31: Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax $39.92M.
- 2023-12-31: Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax $30.92M.
- 2022-12-31: Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax -$1.70M.
- 2021-12-31: Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax $23.68M.
| Period end | Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax |
|---|---|
| 2024-12-31 | $39.92M 10-K · filed 2025-02-10 |
| 2023-12-31 | $30.92M 10-K · filed 2025-02-10 |
| 2022-12-31 | -$1.70M 10-K · filed 2025-02-10 |
| 2021-12-31 | $23.68M 10-K · filed 2025-02-10 |
| 2020-12-31 | $23.83M 10-K · filed 2024-02-13 |
| 2019-12-31 | $15.47M 10-K · filed 2023-02-07 |
| 2018-12-31 | $9.15M 10-K · filed 2022-02-08 |
| 2017-12-31 | $8.45M 10-K · filed 2021-02-09 |
| 2016-12-31 | $2.75M 10-K · filed 2020-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |